{"product_id":"auxly-bcg-matrix","title":"Auxly Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eActionable Strategy Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eAuxly’s BCG Matrix snapshot highlights where its product lines sit amid shifting market share and growth—revealing potential Stars in emerging cannabis segments, Cash Cows in established SKUs, and weaker offerings that may be Dogs or Question Marks. This concise preview teases the strategic implications of each quadrant and the resource moves management faces. Get the full BCG Matrix to access quadrant-level data, prioritized recommendations, and an actionable roadmap to optimize portfolio returns. Purchase now for the complete Word report plus an Excel summary ready for presentation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVape Dominance with Back Forty\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAuxly maintains leading Canadian vape share via Back Forty, capturing ~18% of the 2.0 vape market in 2024 and appealing to value-conscious consumers.\u003c\/p\u003e\n\u003cp\u003eAs vape hardware and tech evolve, Back Forty needs sustained R\u0026amp;D and marketing spend—Auxly invested C$12.4M in vape R\u0026amp;D and brand marketing in FY2024 to defend its position.\u003c\/p\u003e\n\u003cp\u003eWith 2.0 segment revenue growth at ~22% CAGR (2021–2024), Back Forty remains Auxly’s primary growth engine but requires ongoing capital for product innovation and supply scaling.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInfused Pre-Roll Innovation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe infused pre-roll segment is a Star for Auxly, growing at ~25% CAGR (2022–2025) with Auxly holding ~18% Canadian market share in infused pre-rolls as of Q4 2025, driven by extraction expertise and SKUs like Kolab Project and Back Forty infused lines.\u003c\/p\u003e\n\u003cp\u003eConsumers shift to higher-potency, ready-to-use formats: infused pre-rolls rose to ~22% of total cannabis retail sales in 2025, so Auxly must scale automated manufacturing (target: +30% capacity by end-2026) and develop distinctive flavor\/terpene profiles to sustain premium pricing and fend off competitors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKolab Project Premium Concentrates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKolab Project Premium Concentrates sits in Auxly’s BCG matrix as a Star: premium extracts like live resin and rosin grew ~18% CAGR 2020–2024 in Canada, and Kolab holds ~12% share of premium concentrate SKU sales in 2024, driving strong top-line growth.\u003c\/p\u003e\n\u003cp\u003eHigh repeat rates (estimated 65% for premium concentrates) and ASPs ~C$40–60 per gram support margins, but preserving leadership needs strict QC and CAPEX: ~C$3–5M for specialized extraction lines and solventless rosin presses annually.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Distribution Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAuxly’s strategic distribution partnerships across provincial boards are a star asset, delivering estimated 35–45% retail coverage in Ontario and British Columbia as of 2025 and driving top-shelf placement for high-growth SKUs.\u003c\/p\u003e\n\u003cp\u003eBy joining data-sharing programs, Auxly boosted SKU velocity by ~22% in 2024, ensuring new launches reach peak penetration fast and supporting revenue concentration in top provinces.\u003c\/p\u003e\n\u003cp\u003eThis distribution infrastructure enables rapid scale, cuts time-to-reorder, and sustains dominant share in the most lucrative provincial markets.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e35–45% retail coverage in ON+BC (2025)\u003c\/li\u003e\n\u003cli\u003e~22% SKU velocity lift from data-sharing (2024)\u003c\/li\u003e\n\u003cli\u003ePrime shelf placement for high-growth SKUs\u003c\/li\u003e\n\u003cli\u003eFaster scale and reorder cadence for new launches\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNext-Generation Hardware Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAuxly’s investment in proprietary vape hardware and delivery systems keeps it competitive in the fast-growing cannabis tech market; hardware sales grew 28% year-over-year in 2024, supporting a 12% uplift in premium SKU ASPs.\u003c\/p\u003e\n\u003cp\u003ePartnerships with hardware leaders like Greentank let Auxly differentiate from generic offerings, boosting repeat purchase rates by ~18% and expanding market share in vape categories to an estimated 9% in Canada (2024).\u003c\/p\u003e\n\u003cp\u003eHardware R\u0026amp;D and CAPEX remain intensive—capital expenditure rose to C$14.2M in FY2024—but this positions Auxly as a leader in consumption innovation and higher-margin product segments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 hardware revenue +28%\u003c\/li\u003e\n\u003cli\u003ePremium SKU ASPs +12%\u003c\/li\u003e\n\u003cli\u003eRepeat purchases +18%\u003c\/li\u003e\n\u003cli\u003eEstimated vape market share 9% (Canada, 2024)\u003c\/li\u003e\n\u003cli\u003eFY2024 CAPEX C$14.2M\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAuxly’s Growth Engines: Back Forty, Infused PR, Kolab \u0026amp; Distribution Driving Rapid Share Gains\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAuxly’s Stars: Back Forty vape (~18% 2.0 share, 22% CAGR 2021–24), Infused pre-rolls (~18% share, 25% CAGR 2022–25), Kolab premium concentrates (~12% premium SKU share, 18% CAGR 2020–24), plus distribution (35–45% ON+BC coverage, +22% SKU velocity 2024); FY2024 vape R\u0026amp;D C$12.4M, hardware CAPEX C$14.2M, extract CAPEX C$3–5M.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003eShare\u003c\/th\u003e\n\u003cth\u003eCAGR\u003c\/th\u003e\n\u003cth\u003eKey spend\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBack Forty\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003ctd\u003e22%\u003c\/td\u003e\n\u003ctd\u003eC$12.4M R\u0026amp;D\/marketing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInfused PR\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003ctd\u003e25%\u003c\/td\u003e\n\u003ctd\u003e+30% capacity target\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKolab\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003ctd\u003eC$3–5M extract CAPEX\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistribution\u003c\/td\u003e\n\u003ctd\u003e35–45%\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e+22% SKU velocity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eBCG Matrix for Auxly: strategic classification of units into Stars, Cash Cows, Question Marks, and Dogs with investment, hold, or divest guidance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Auxly BCG Matrix showing each unit’s position for quick strategic decisions and easy export to presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBack Forty Dried Flower\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBack Forty dried flower holds a leading share in Auxly Cannabis Group’s value-priced dried-flower segment, delivering steady volume in a mature market that grew low-single-digits in 2024; Auxly reported C$78m in dried-flower revenue in FY2024, with Back Forty a core contributor.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eForay Edibles and Softchews\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eForay Edibles and softchews sit as Auxly Brands' Cash Cows within the BCG matrix: Foray reported C$18.6M in 2024 edibles revenue, benefiting from mature category demand and 85% capacity utilization at the Red Deer facility, so little capex is needed to sustain output.\u003c\/p\u003e\n\u003cp\u003eHigh brand recognition (Foray 62% aided awareness in Canada, 2024) and standardized manufacturing yield gross margins near 45%, allowing Auxly to reliably fund corporate overhead and R\u0026amp;D from predictable softchew sales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDosecann Extraction Facilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDosecann Extraction Facilities is a mature infrastructure asset that converted 6,400 kg of biomass into 1,280 kg of extract in 2024 (20% yield), producing oils and distillates with \u0026gt;92% purity and lowering COGS by ~18% versus tolling alternatives.\u003c\/p\u003e\n\u003cp\u003eAs a centralized hub, Dosecann services multiple Auxly brands, cutting per-unit processing costs and contributing ~15% of corporate gross margin in FY2024 while maximizing free cash flow from each sale.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eValue-Tier Pre-Roll Multi-Packs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eValue-tier, non-infused pre-roll multi-packs are a cash cow for Auxly in Canada, with the category reaching roughly CAD 420 million in 2024 and Auxly holding an estimated 12% share, driving steady gross margins via scale manufacturing and fast retail turnover.\u003c\/p\u003e\n\u003cp\u003eBecause the market is mature and predictable, Auxly focuses on lowering unit costs and optimizing distribution rather than heavy marketing, preserving cash flow—here’s the quick math: a 5% reduction in COGS on a CAD 50m segment lifts gross profit by ~CAD 2.5m.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket size ~CAD 420m (2024)\u003c\/li\u003e\n\u003cli\u003eAuxly share ~12% (est. 2024)\u003c\/li\u003e\n\u003cli\u003eHigh SKU turnover, retail sell-through \u0026gt;60% monthly\u003c\/li\u003e\n\u003cli\u003ePrimary lever: reduce COGS 3–7% to boost EBITDA\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEstablished Medical Channel Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAuxly’s Established Medical Channel is a Cash Cow: Canada’s medical cannabis market grew ~3% in 2024, but Auxly’s ~20,000 registered patients (company filings, 2024) deliver recurring revenue and ~35% gross margins that stabilize cash flow.\u003c\/p\u003e\n\u003cp\u003eThe channel needs lower marketing spend due to high patient retention and physician referrals, supporting predictable EBITDA and helping service Auxly’s debt (net debt ~CAD 45m, 2024).\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRecurring revenue from ~20,000 patients\u003c\/li\u003e\n\u003cli\u003e~35% gross margins\u003c\/li\u003e\n\u003cli\u003eLower marketing spend vs recreational\u003c\/li\u003e\n\u003cli\u003eSupports debt service (net debt ~CAD 45m)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAuxly 2024: Stable cash flow from flower, edibles, Dosecann \u0026amp; 20k medical patients\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBack Forty, Foray edibles\/softchews, Dosecann extraction, value-tier pre-rolls, and the established medical channel generate steady cash flow for Auxly in 2024—key metrics: dried-flower revenue C$78m, Foray edibles C$18.6m, Dosecann yield 20% (6,400 kg→1,280 kg), value pre-roll market ~CAD420m (Auxly ~12%), ~20,000 medical patients, corporate net debt ~CAD45m.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBack Forty (flower)\u003c\/td\u003e\n\u003ctd\u003eC$78m rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eForay edibles\u003c\/td\u003e\n\u003ctd\u003eC$18.6m rev; 85% cap util\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDosecann\u003c\/td\u003e\n\u003ctd\u003e6,400 kg→1,280 kg; 20% yield\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePre-rolls\u003c\/td\u003e\n\u003ctd\u003eMarket CAD420m; Auxly ~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical channel\u003c\/td\u003e\n\u003ctd\u003e~20,000 patients; ~35% GM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet debt\u003c\/td\u003e\n\u003ctd\u003e~CAD45m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You’re Viewing Is Included\u003c\/span\u003e\u003cbr\u003eAuxly BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing on this page is the exact BCG Matrix report you'll receive after purchase—fully formatted, no watermarks or demo content, and ready for presentation or editing.\u003c\/p\u003e\n\u003cp\u003eThis preview mirrors the finished document available for download post-purchase, crafted with clear visuals and market-informed positioning for immediate strategic use.\u003c\/p\u003e\n\u003cp\u003eOnce purchased, the same file shown here is delivered—professionally designed and ready to plug into business plans, pitch decks, or client presentations.\u003c\/p\u003e\n\u003cp\u003eNo mockups or placeholders: the preview is the final product you’ll get, streamlined for clarity and practical decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748470731129,"sku":"auxly-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/auxly-bcg-matrix.png?v=1772208481","url":"https:\/\/growthsharematrix.com\/products\/auxly-bcg-matrix","provider":"Growth Share Matrix","version":"1.0","type":"link"}